Global Fund to Fight AIDS, Tuberculosis and Malaria Debate

Full Debate: Read Full Debate

Global Fund to Fight AIDS, Tuberculosis and Malaria

Imogen Walker Excerpts
Tuesday 4th November 2025

(1 day, 12 hours ago)

Westminster Hall
Read Full debate Read Hansard Text

Westminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.

Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.

This information is provided by Parallel Parliament and does not comprise part of the offical record

Imogen Walker Portrait Imogen Walker (Hamilton and Clyde Valley) (Lab)
- Hansard - -

It is a pleasure to serve under your chairmanship, Mr Dowd. I am grateful to the hon. Member for Winchester (Dr Chambers) for securing this debate. I pay tribute to his work on global health as secretary to the all-party parliamentary group on antimicrobial resistance and as a member of the APPG on maternity. I am also grateful for the efforts of so many here who have dedicated themselves to the fight against HIV/AIDS, TB and malaria for years. I am thankful for the contribution of every hon. Member, including the thoughtful and passionate speech from my hon. Friend the Member for Worthing West (Dr Cooper). I will do my best to address the points that have been raised in the time I have.

I know that hon. Members will be aware of this Government’s commitment to the mission of the Global Fund. Indeed, we can all be proud that the United Kingdom helped to establish the Global Fund back in 2002. The UK is the fund’s third largest investor, contributing £5.5 billion so far. Members should be in no doubt that this Government value our ongoing partnership with the Global Fund; it is essential to maintaining and accelerating progress in global health.

It is hard to overstate the importance of the Global Fund in transforming the fight against these diseases. Since 2002, with support from the UK and many others, the Global Fund partnership has helped to save 70 million lives and reduce deaths from AIDS, TB and malaria by 63%—that is remarkable. Importantly, the Global Fund has helped to build more resilient and sustainable health systems that help us to fight AIDS, TB and malaria, and it helps countries to support and improve the health of their populations more broadly, from addressing the threat of antimicrobial resistance to making progress on preventing new diseases from becoming epidemics, or even pandemics.

Yet our work is far from done. Tragically, every passing minute, a child under the age of five dies of malaria. Notwithstanding all the progress that we have made, tuberculosis remains the world’s deadliest infectious disease. Nearly 14 million children are growing up without one or both of their parents—lost to AIDS-related causes, mostly in sub-Saharan Africa. Sibu Sibaca from South Africa spent her childhood caring for her parents, until AIDS took them from her when she was just 16. Her adult life is devoted to making the case for action to ensure that others do not have to go through this, and she spoke so powerfully alongside my right hon. Friend the Foreign Secretary at the United Nations General Assembly in New York, and at a reception co-hosted with South Africa’s Foreign Minister in London a few weeks ago. My hon. Friend the Member for Exeter (Steve Race) has spoken about the importance of co-operation, and of course he is right.

Wherever we can, we are making the case for how the Global Fund can continue to be a powerful solution multiplier—pooling investments, making economies of scale and maximising our collective impact. Let me take this opportunity to shine a light on how cutting-edge advancements are changing what is possible now. Take Lenacapavir, a twice-yearly injectable that could be a game changer in the fight against HIV. Thanks to partners, including Unitaid, a recent landmark deal will bring it to market at $40 per person. That is a staggering drop from the original price of over $28,000. Thanks to the Global Fund, 2 million doses will be distributed to people in low and middle-income countries over the next two years, saving lives and giving people a chance at a better future.

The final replenishment summit in Johannesburg on 21 November matters immensely, and we are proud to be working in partnership with the Government of South Africa to make it happen. We celebrate all that we have achieved through the Global Fund in its 23 years so far, and we focus on what comes next: raising billions for the fight against AIDS, TB and malaria, with public and private investors working together; backing countries’ ambitions to invest more in health; harnessing private sector expertise, including world-class UK science to make the most of the latest innovations and improve access to medicines; and committing to work together in new ways to support countries on their path to self-reliance, and to reshape the global health architecture for the future. That is how we make sure our efforts add up to more than the sum of their parts so that the Global Fund can continue its lifesaving, life-changing work around the world.

I want to build on what other hon. Members have said by underlining what we stand to gain if we continue to make progress in the months and years ahead. As the hon. Members for Strangford (Jim Shannon) and for Winchester said, there will be more children growing up with their parents, more parents spared the heartbreak of burying a child, more families spared from devastating loss, more communities able to thrive and more economies able to prosper. That is what people everywhere want to see. I am not foolish enough to attempt to match the poetry of Bruce Springsteen, but we will keep working until people everywhere feel the benefits of better health in our lives.

Question put and agreed to.